


Gentle

Non-Thermal

Long-Term
Mission & Vision
Resolving Atrial Fibrillation at its Origin


TECHNOLOGY
A Disruptive Approach to Rhythm restoration

THE DISRUPTION
AtriAN’s Business Pathway

Growing Market

Robust and Innovative Intellectual Property (IP)

Unique Solution

Funding in Place

Unmet Need

First In Human (FIH) Trials
R & D
Research & Development
gentle Pulsed Fields
Autonomics Remodeling
Sub-Xiphoid Approach

News
Resources & News
Nulla libero mauris
Integer fringilla, purus sed suscipit imperdiet, erat justo tincidunt est, tempor tempus diam massa in justo. Pellentesque laoreet faucibus lorem, eu posuere neque accumsan sed. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis...
Lorem ipsum dolor sit amet
Morbi mauris libero, iaculis non vulputate vel, bibendum ut arcu. Vivamus ornare rutrum ipsum lacinia convallis. Cras id blandit arcu, sit amet efficitur magna. Ut in metus porttitor, pretium ipsum ac, ultrices justo. Phasellus in tortor tortor. Sed at urna...
AtriAN Medical’s Clinical Data Highlighted at the 2022 AF Symposium
Pioneering cardiac autonomic pulsed field ablation (PFA) technology provides a unique option for enhancing the durability of AF ablation.
Get Started